RNAseq libraries were prepared using the Illumina ScriptSeq v2 Library Preparation Kit were removed using Trimmomatic (27) . The Ensembl Mus musculus GRCm38 reference 1 5 3 genome (version 76) was downloaded from the Ensembl website (28) and reads were mapped 1 5 4 to the genome using TopHat2 (29) . HTSeq (30) was used to quantify expression as the gene 2 3 8 are the first to demonstrate the capacity of Mtb to inhibit IFNAR-signaling. The lack of 2 3 9 investigation into this capacity of the pathogens might be explained by the proposed overall 2 4 0 role of type I IFN in exacerbation of disease outcomes (2, (4) (5) (6) . Signaling via the IFNAR induces the formation the IFN-stimulated gene factor 3 (ISGF3) 2 4 4 complex and or STAT1:STAT1 homodimerization which both translocate into the nucleus and 2 4 5 bind to ISRE or GAS, respectively, leading to the transcription of hundreds of genes involved in regulated genes that are up-or down-regulated during Mtb infection in Ifn-β -/--derived BMDMs. We analyzed the following experimental groups: 1. uninfected, untreated (UI), 2. uninfected 2 5 1 IFN-β treated (UI+) and 3. Mtb H37Rv infected and treated (Mtb+) BMDMs (Table S1 ). The 2 5 2
RNAseq data was reproducible as indicated by principle component analysis (PCA), hierarchal 2 5 3 clustering and Pearson correlation ( Figure S1 ). All three analyses depicted a satisfactory 2 5 4 degree of clustering between biological replicates with the exception of one outlier 2 5 5 (HPGL0627), which was excluded from further analysis ( Figure S1 and Table S1 ). In order to 2 5 6 identify IFN-β-stimulated genes that exhibited differential expression in Mtb-infected BMDMs, we first characterized all of the IFN-β-regulated genes in our experimental system. To that 2 5 8 purpose we compared the gene expression of uninfected, untreated (UI) to uninfected, IFN-β 2 5 9 treated (UI+) conditions. We identified a total of 1144 IFN-β-stimulated genes and 956 genes 2 6 0 with reduces expression (> 2fold change) ( Figure S2A , Table S1 ). Next, in order to identify all 2 6 1 of the genes that are impacted by Mtb-infection we compared gene expression levels between 2 6 2 the UI +IFNβ condition and the Mtb H37Rv infected and treated (Mtb+) and found 1296 2 6 3 upregulated and 1294 downregulated (> 2fold change and an adjusted p-value <0.05) genes 2 6 4 ( Figure S2B , Table S1 ). Finally, Mtb-infection causes the deregulation of many genes that are 2 6 5 not regulated by IFN-β but will be included in the UI+ versus Mtb+ contrast. The overlap 2 6 6 between these two gene sets was determined to be 309 genes with reduced expression and 2 6 7 170 with increased expression for a total of 479 deregulated genes ( Figure S2C , Table S1 ). To extend the results of our RNAseq analysis, we determined protein expression and secretion 2 6 9 levels of selected targets in Ifn-β -/-BMDMs infected with Mtb in the presence or absence of 2 7 0 IFN-β ( Figure 2B ). The selection of candidate gene products for follow-up studies was based 2 7 1 on magnitude of deregulation and availability of antibodies (see list of 479 genes in Table S1 ). Rnf144A and Rnf144B proteins were not significantly upregulated upon treatment with IFN-β 2 7 3 1 4 ( Figure 2C ) which may reflect a low fold-increase at the RNA level as illustrated in the heatmap 2 7 4 ( Figure 2B ), however IFI204, IFIT1, MX1 and IIGP1 were strongly induced after treatment with 2 7 5 IFN-β ( Figure 2C -D). For all targets, we observed some degree of downregulation in IFN-β-2 7 6 treated cells infected with Mtb. In addition, we used ELISA to demonstrate the strong inhibition 2 7 7 of IFN-β-driven secretion of CCL12 by Mtb infection (Figure 2E ). In conclusion, these data show a strong correlation of the RNAseq analysis with protein data for the subset of 309 IFN-β- regulated genes that are repressed by Mtb infection ( Figure 2B and Table S1 ). We additionally 2 8 0 investigated some of the 170 genes that were strongly upregulated in the 479 genes set ( Table   2 8 1 S1) and characterized several cytokine/chemokine targets using a combination of both these cytokines in Mtb-infected cells is independent of IFNAR-signaling and that their 2 8 8 upregulation caused by addition of IFN-β can be inhibited by Mtb ( Figure S1 ). Overall, this 2 8 9 analysis shows that this subset of 170 of Mtb-deregulated genes after IFN-β addition that is 2 9 0 upregulated provides less insights because many of the genes seem to be upregulated by Mtb 2 9 1 infection alone. We discovered that Mtb inhibits signaling via IFNAR and now we investigated further at We found that surface expression levels of IFNAR1 and IFNAR2 using flow cytometry 2 9 8 remained unchanged by Mtb infection ( Figure 3A ). After stimulation of IFNAR1/R2 by IFN-β, 2 9 9 the cytosolic protein tyrosine kinases JAK1 and TYK2 are recruited and phosphorylated. We Besides STAT1, other STAT isoforms may be stimulated by type I IFN signaling. STAT2 3 2 0 becomes phosphorylated and heterodimerizes with pSTAT1 and IRF9 to form the ISGF3 3 2 1 complex, which translocates into the nucleus to induce transcription of genes containing 3 2 2 interferon stimulated regulatory elements (ISREs) (3). In addition, it has also been shown that 3 2 3 STAT3 can be induced by type I IFNs to regulate transcription of different gene subsets (38).
2 4
We discovered that Mtb also inhibited the tyrosine phosphorylation of STAT2 ( Figure 4C ). However, Mtb actually induced phosphorylation of STAT3 ( Figure 4C ). STAT3 phosphorylation 3 2 6
can inhibit type I IFN-mediated signaling, although this occurs at the level of nuclear The levels of IFN-β production by mycobacteria-infected cells vary depending on the 3 3 0 mycobacterial species and, in the context of Mtb, the specific strain that is used for the 3 3 1 infection (24, 41, 42) . We sought to test if the difference in type I IFNs production observed for to RNI stress (51). It is thus possible that NO levels in the infected cells that actually generate 3 7 2 the NO fail to accumulate to bactericidal threshold levels in vivo due to diffusion and dilution as infected cells. In any case, the potential of Mtb to inhibit IFN-β-mediated NO production will be 3 7 5 advantageous for the pathogen. We do not believe that the recently reported direct bactericidal cells should not be different from wild-type BMDM ( Figure 1E ). It seems confounding that Mtb would want to both induce IFN-β production and simultaneously 3 8 0 inhibit it's signaling. Considering that Mtb is a facultative intracellular pathogen, we expression of the Nos2 gene is not affected by Mtb which we think is due to the early timepoint 4 1 0 (4hpi) selected for the RNAseq analysis. Nos2 can be induced by signaling via many TLRs and 4 1 1 2 0 cytokine receptors (43, 62). In our system, Mtb infection causes a strong induction of TNF 4 1 2 secretion which is amplified by addition of IFN-β ( Figure S3 ). Consequently, we believe that 4 1 3 TNF is the most likely cause for the observed late induction of NOS2, especially since it has 4 1 4 been noted before that IFN-β and TNF synergistically mediate the induction of Nos2 gene NOS2 is only detected after 72h to 96h ( Figure 1E ). SOCS1, SOCS3, and USP18 are 4h, it is highly unlikely that the molecular mechanism of at least the early inhibition is context, it is less surprising that Mtb has also evolved mechanisms to limit production of type I induced IFN-β production in an ESX-1-dependent manner in bone marrow-derived dendritic BMDMs were infected with Mtb H37Rv in the presence or absence of 1000pg/ml IFN-β.
0 1
Bacterial burden was determined as in Fig. 1A . All data shown are presented as mean ± immunoblotted for pJAK1 (Y1022/1023), total JAK1, pTYK2 (Y1054/1055), and total TYK2. Densitometry was performed using ImageJ software and phosphorylated protein bands were 5 2 7 normalized to total signal for each condition. Data and densities shown represent one 5 2 8
representative experiment out of three. from the lower transwell were collected at 4hpi and immunoblotted for pSTAT1, total STAT1, or in the cytosol (24). All these factors initiate the STING/TBK1 signaling pathway that leads to 5 5 7 activation of the transcription factor IRF-3 and increased IFN-β production. The secreted IFN-β 5 5 8 acts on bystander cells to increase secretion of IL-10 and IL-1Ra which lead to increased host 
